GPX3 and ovarian carcinoma: We found that downregulation of GPX3 expression inhibited metastasis in breast cancer (MDA-MB-231, BT-549), colorectal cancer (Lovo, SW480), gastric cancer (MKN45), and ovarian cancer (Ovcar-4).